Business Of Biotech
The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, regulatory, and commercial challenges you’ll face as you navigate your company from an idea to success in the clinic and beyond. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by Life Science Connect.
- Update frequency
- every 7 days
- Average duration
- 49 minutes
- Episodes
- 270
- Years Active
- 2020 - 2025
Keeping Cell Therapy Clinicals On The Rails With Brian Culley
We love to hear from our listeners. Send us a message.
Like most biotechs, Lineage Cell Therapeutics faced some significant challenges as it navigated multiple clinical trials, one of them in an agin…
Orchard Tx's Bobby Gaspar On Manufacturing Hematopoietic Stem Cells
We love to hear from our listeners. Send us a message.
In this third installment of our cell & gene therapy manufacturing miniseries, Erin Harris and Matt Pillar sit down with Orchard Therapeutics CE…
Acepodia's Approach To ACC & CAR Manufacturing Scalability
We love to hear from our listeners. Send us a message.
Acepodia CEO, President, & Co-founder Dr. Sonny Hsiao and Dr. Mark Gilbert, VP of R&D, join Erin Harris and Matt Pillar for a discussion on the …
The AAV Vector Challenge With Selecta's Dr. Carsten Brunn
We love to hear from our listeners. Send us a message.
The Business of Biotech kicks off our Cell & Gene Miniseries with Dr. Carsten Brunn, President & CEO at Selecta Biosciences. Guest host Erin Har…
A Look Behind, A Look Ahead With Allan Shaw
We love to hear from our listeners. Send us a message.
The Business Of Biotech kicks off the new year with an up-close-and-personal talk with biotech investor and CFO extraordinaire Allan Shaw. We ta…
Manipulating Milestones In Pandemic Times With AGTC's Sue Washer
We love to hear from our listeners. Send us a message.
The COVID-19 pandemic continues to disrupt biopharma clinical trials, especially those conducted with at-risk patient populations. From patient …
Gene Therapy Manufacturing At-Scale With Geoff MacKay
We love to hear from our listeners. Send us a message.
Listen in as AVROBIO President & CEO Geoff MacKay tells the Business Of Biotech about the technology his company is using to drive at-scale gene…
Bacterial Therapy: Modulation of the Microbiome With Dr. Bernat Olle
We love to hear from our listeners. Send us a message.
Dr. Bernat Olle discusses the pioneering work his company, Vedanta Biosciences, is doing to modulate the immune system and provide colonization …
Foundations Of Biopharma Finance With Smital Shah
We love to hear from our listeners. Send us a message.
Smital Shah brings a trifecta of chemical engineering, consulting, and finance experience earned at heavyweight companies like JP Morgan, Leerin…
Off-The-Shelf CAR T-Cell Therapy with John McKearn, Ph.D.
We love to hear from our listeners. Send us a message.
Find out what drove John McKearn, Ph.D. & CEO at Wugen, out of the lab at Pfizer and on to his quest to develop off-the-shelf cell therapies for…
CAR T Therapy Cost Control With Laurence Cooper, M.D., Ph.D.
We love to hear from our listeners. Send us a message.
Controlling the cost of personalized medicine: We go behind the scenes of the effort to build a system that simplifies production and reduces th…
010: Gap Analysis With Dr. Pablo Valenzuela & Cristián Hernández-Cuevas
We love to hear from our listeners. Send us a message.
We're joined by biopharma pioneer Dr. Pablo Valenzuela and rising star Cristián Hernández-Cuevas for a candid discussion on biopharma's compute …
009: CMC Considerations For In-Human Studies with Drs. Edith Perez & Nathan Ihle
We love to hear from our listeners. Send us a message.
Bolt Biotherapeutics CMO Dr. Edith Perez and VP of CMC & Quality Dr. Nathan Ihle bring a unique combination of patient and production process ex…
008: Commitment To GMP With Dr. Shabbir Anik
We love to hear from our listeners. Send us a message.
Sutro Biopharma Chief Technical Operations Officer Shabbir Anik has contributed to 15 INDs and 10 NDA’s over the course of his distinguished car…
007: Quality Data For FDA Submissions With Dr. Robert Hariri
We love to hear from our listeners. Send us a message.
If ever a biotech unwittingly begged for FDA scrutiny by virtue of its business model, it was Celularity. The company is working on a host of bi…
Summer Sessions 8: Dr. Gaurav Shah, Rocket's Chief Gene Therapist & Virtuoso
We love to hear from our listeners. Send us a message.
Rocket Pharmaceuticals CEO Dr. Gaurav Shah shares the parallels between his leadership in the gene therapy space and his successes as a Grammy®-…
Summer Sessions 7: Dr. Randall Schatzman & The New Fundraising Norm
We love to hear from our listeners. Send us a message.
Dr. Randy Schatzman, CEO at Bolt Biotherapeutics, discusses his company's adjustment to pandemic disruption on the fundraising trail. He walks u…
Summer Sessions 6: Alexis Peyroles On Myeloid Cells, Transplants, & Immuno-Oncology Inspiration
We love to hear from our listeners. Send us a message.
OSE Immunotherapeutics CEO Alexis Peyroles joins The Business Of Biotech: Summer Executive Sessions to discuss myeloid cells' role in immunology…
Summer Sessions 5: Dr. Christopher Anzalone Takes RNAi Beyond The Liver
We love to hear from our listeners. Send us a message.
Arrowhead Pharma CEO Christopher Anzalone, Ph.D. gives us the inside story on the stake his company claimed on the now re-burgeoning RNAi space,…
Summer Sessions 4: Dr. Loretta Itri On Taking ADCs Across The Finish Line
We love to hear from our listeners. Send us a message.
While Immunomedics CMO Loretta Itri, M.D. is no stranger to taking drugs across the commercial finish line in big pharma, her most recent win wi…